Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Genesis Healthcare stock in Canada | $0.5

Own Genesis Healthcare shares in just a few minutes.


Fact checked

Genesis Healthcare, Inc is a medical care facilities business based in the US. Genesis Healthcare shares (GEN.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $0.5 – a decrease of 3.85% over the previous week. Genesis Healthcare employs 55,000 staff and has a trailing 12-month revenue of around $4.1 billion.

How to buy shares in Genesis Healthcare

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: GEN in this case.
  5. Research Genesis Healthcare shares. The platform should provide the latest information available.
  6. Buy your Genesis Healthcare shares. It's that simple.

How has Coronavirus impacted Genesis Healthcare's share price?

Since the stock market crash in March caused by coronavirus, Genesis Healthcare's share price has had significant negative movement.

Its last market close was $0.5, which is 71.10% down on its pre-crash value of $1.73 and 46.00% down on the lowest point reached during the March crash when the shares fell as low as $0.73.

If you had bought $1,000 worth of Genesis Healthcare shares at the start of February 2020, those shares would have been worth $569.54 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $331.13.

Genesis Healthcare share price

Use our graph to track the performance of GEN stocks over time.

Genesis Healthcare shares at a glance

Information last updated 2020-12-26.
Latest market close$0.5
52-week range$0.4 - $1.86
50-day moving average $0.5141
200-day moving average $0.6339
Wall St. target price$0.53
PE ratio 1.2858
Dividend yield N/A (0%)
Earnings per share (TTM) $0.245

Compare online trading platforms

Name Product Available asset types Stock Fee Option Fee Account Fee ETF Transaction Cost
Wealthsimple Trade
Stocks, ETFs
Get a $25 bonus when you open a Wealthsimple Trade account and deposit and trade at least $100.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, IPOs, Precious Metals
$9.95 + $1 per contract
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Interactive Brokers
Stocks, Bonds, Options, Mutual Funds, ETFs, Currencies, Futures, Precious Metals
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0 (if monthly commissions are greater than or equal to US$10.00)
Min. $1.00, Max. 0.5% of trade value
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.

Compare up to 4 providers

Name Product Minimum deposit to invest Funding methods Management fee Available asset types
Wealthsimple Invest
Direct deposit, Bank transfer
0.40% - 0.50%
Stocks, Bonds, ETFs, Commodities
Get a $50 bonus when you open and fund your first Wealthsimple Invest account with a minimum initial deposit of at least $500. Trade and Cash accounts are not eligible.
CI Direct Investing (formerly WealthBar)
Direct deposit, Bank transfer
0.35% - 0.60%
Mutual Funds, ETFs
CI Direct Investing offers access to an exclusive and personalized investment portfolio. Get up to $10,000 managed free for a year when you sign up for your first CI Direct Investing account and fund your account.
Direct deposit, Bank transfer, Automatic bank withdrawals
Receive a cash bonus of $50.00-$225.00 when you open a new Justwealth account. RESP accounts require no minimum deposit to begin investing.
Automatic bank withdrawals
The Moka app rounds up every purchase you make to the nearest dollar and invests the spare change into low-cost exchange-traded funds (ETFs).

Compare up to 4 providers

Name Product Minimum Opening Deposit Commission Available Markets Platforms
Minimum US$25
Shares Desktop, Web Trading, Mobile Trading, MetaTrader 4
CFDs are leveraged products which involves greater risk than using cash resources only. You could lose all or more of your initial investment. Trade 80+ currency pairs and 220+ CFDs in equities, commodities and indices on

Compare up to 4 providers

Is it a good time to buy Genesis Healthcare stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Genesis Healthcare price performance over time

Historical closes compared with the last close of $0.5

1 week (2021-01-15) -31.51%
1 month (2020-12-22) -7.41%
3 months (2020-10-22) 2.04%
6 months (2020-07-22) -39.12%
1 year (2020-01-22) -67.95%
2 years (2019-01-22) -68.75%
3 years (2018-01-22) -47.55%
5 years (2016-01-22) -81.82%

Is Genesis Healthcare under- or over-valued?

Valuing Genesis Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genesis Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Genesis Healthcare's P/E ratio

Genesis Healthcare's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, Genesis Healthcare shares trade at around 1x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Genesis Healthcare's EBITDA

Genesis Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$160.9 million.

The EBITDA is a measure of a Genesis Healthcare's overall financial performance and is widely used to measure a its profitability.

Genesis Healthcare financials

Revenue TTM USD$4.1 billion
Gross profit TTM USD$2.1 billion
Return on assets TTM -2.54%
Return on equity TTM 0%
Profit margin -1.52%
Book value $-7.36
Market capitalisation USD$90.5 million

TTM: trailing 12 months

How to short and sell Genesis Healthcare shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "GEN.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 539,011 Genesis Healthcare shares held short by investors – that's known as Genesis Healthcare's "short interest". This figure is 28.6% down from 755,000 last month.

There are a few different ways that this level of interest in shorting Genesis Healthcare shares can be evaluated.

Genesis Healthcare's "short interest ratio" (SIR)

Genesis Healthcare's "short interest ratio" (SIR) is the quantity of Genesis Healthcare shares currently shorted divided by the average quantity of Genesis Healthcare shares traded daily (recently around 855573.01587302). Genesis Healthcare's SIR currently stands at 0.63. In other words for every 100,000 Genesis Healthcare shares traded daily on the market, roughly 630 shares are currently held short.

However Genesis Healthcare's short interest can also be evaluated against the total number of Genesis Healthcare shares, or, against the total number of tradable Genesis Healthcare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Genesis Healthcare's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Genesis Healthcare shares in existence, roughly 0 shares are currently held short) or 0.0069% of the tradable shares (for every 100,000 tradable Genesis Healthcare shares, roughly 7 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Genesis Healthcare.

Find out more about how you can short Genesis Healthcare stock.

Genesis Healthcare share dividends

We're not expecting Genesis Healthcare to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have Genesis Healthcare's shares ever split?

Genesis Healthcare's shares were split on a 10:11 basis on 4 April 2013. So if you had owned 11 shares the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Genesis Healthcare shares – just the quantity. However, indirectly, the new 10% higher share price could have impacted the market appetite for Genesis Healthcare shares which in turn could have impacted Genesis Healthcare's share price.

Genesis Healthcare share price volatility

Over the last 12 months, Genesis Healthcare's shares have ranged in value from as little as $0.4 up to $1.86. A popular way to gauge a stock's volatility is its "beta".

GEN.US volatility(beta: 1.72)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Genesis Healthcare's is 1.716. This would suggest that Genesis Healthcare's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Genesis Healthcare overview

Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of April 23, 2020, it provided inpatient services through a network of approximately 400 skilled nursing facilities and assisted/senior living communities in 25 states; and supplied rehabilitation and respiratory therapy to approximately 1,200 healthcare locations in 44 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site